国药一致：陈常兵辞去公司副总经理职务

Group 1 - The core point of the article is the resignation of Mr. Chen Changbing from the position of Deputy General Manager of China National Pharmaceutical Group Corporation (国药一致), effective immediately upon submission of his resignation report to the board, while he will continue to hold other positions within the company [1] - For the first half of 2025, the revenue composition of China National Pharmaceutical Group Corporation is as follows: 70.21% from pharmaceutical wholesale, 29.28% from pharmaceutical retail, and 0.51% from other products [1] - As of the time of reporting, the market capitalization of China National Pharmaceutical Group Corporation is 13.8 billion yuan [1]